The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2

NCT06523400 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy

Interventions

DRUG: Mexiletine granules for prolonged-release oral suspension
DRUG: Placebo

Sponsor

Lupin Ltd.

Collaborators

[object Object]